8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate has been researched along with valine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SH; Hwang, SH; Kim, BR; Kim, HC; Lee, BH; Lee, JH; Nah, SY; Pyo, MK; Rhim, H; Shin, TJ | 1 |
1 other study(ies) available for 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and valine
Article | Year |
---|---|
A role for the Val291 residue within the transmembrane domain 2 in diltiazem- and TMB-8 [3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester]-mediated 5-hydroxytryptamine type 3A receptor regulations.
Topics: Amino Acid Sequence; Animals; Diltiazem; Dose-Response Relationship, Drug; Female; Gallic Acid; Ion Channel Gating; Membrane Potentials; Mice; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Oocytes; Patch-Clamp Techniques; Protein Structure, Tertiary; Receptors, Serotonin, 5-HT3; Valine; Xenopus laevis | 2009 |